Chronic lung allograft dysfunction is a heterogeneous entity limiting long-term survival after lung transplantation. Different clinical phenotypes (bronchiolitis obliterans syndrome [BOS]-neutrophilic BOS-restrictive allograft syndrome [RAS]) have been identified but the mechanisms remain elusive.status: publishe
Chronic lung allograft dysfunction and its main phenotypes, bronchiolitis obliterans syndrome (BOS) ...
Lung transplantation (LTx) is the final treatment option for patients suffering from end-stage lung ...
Chronic lung allograft dysfunction (CLAD) remains the major barrier to long-term success after lung ...
Chronic lung allograft dysfunction is a heterogeneous entity limiting long-term survival after lung ...
Chronic lung allograft dysfunction (CLAD) remains a major hurdle limiting long-term survival post lu...
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Chronic lung allograft dysfunction (CLAD, an umbrella term which encompasses two subtypes—restrictiv...
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Chronic lung allograft dysfunction (CLAD) is the major limitation of long-term survival after lung t...
International audienceChronic lung allograft dysfunction (CLAD) is the major limitation of long-term...
BACKGROUND: Chronic lung allograft dysfunction (CLAD) remains a major risk factor for death after lu...
Chronic lung allograft dysfunction (CLAD) remains a frequent and troublesome complication after lung...
Lung transplantation is currently considered as an ultimate live-saving treatment for selected patie...
Lung transplantation is the treatment of choice for patients with end-stage lung disease. However, l...
Chronic lung allograft dysfunction (CLAD) was recently introduced as an overarching term mainly to c...
Chronic lung allograft dysfunction and its main phenotypes, bronchiolitis obliterans syndrome (BOS) ...
Lung transplantation (LTx) is the final treatment option for patients suffering from end-stage lung ...
Chronic lung allograft dysfunction (CLAD) remains the major barrier to long-term success after lung ...
Chronic lung allograft dysfunction is a heterogeneous entity limiting long-term survival after lung ...
Chronic lung allograft dysfunction (CLAD) remains a major hurdle limiting long-term survival post lu...
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Chronic lung allograft dysfunction (CLAD, an umbrella term which encompasses two subtypes—restrictiv...
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Chronic lung allograft dysfunction (CLAD) is the major limitation of long-term survival after lung t...
International audienceChronic lung allograft dysfunction (CLAD) is the major limitation of long-term...
BACKGROUND: Chronic lung allograft dysfunction (CLAD) remains a major risk factor for death after lu...
Chronic lung allograft dysfunction (CLAD) remains a frequent and troublesome complication after lung...
Lung transplantation is currently considered as an ultimate live-saving treatment for selected patie...
Lung transplantation is the treatment of choice for patients with end-stage lung disease. However, l...
Chronic lung allograft dysfunction (CLAD) was recently introduced as an overarching term mainly to c...
Chronic lung allograft dysfunction and its main phenotypes, bronchiolitis obliterans syndrome (BOS) ...
Lung transplantation (LTx) is the final treatment option for patients suffering from end-stage lung ...
Chronic lung allograft dysfunction (CLAD) remains the major barrier to long-term success after lung ...